DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,718 followers.

RT @FrontOncology: New research: DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma: Background Glioblastoma is one of…

23 Feb 2024

Reply Repost Favourite

New research: DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma: Background Glioblastoma is one of the most aggressive primary brain tumors, with a poor outcome despite multimodal treatment. Methylation of the MGMT… https://t.co/1qYbC

23 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.